Fierce Biotech August 9, 2024
Heather Landi

Zimmer Biomet plans to acquire AI surgical guidance company OrthoGrid Systems to expand its market share in hip replacement procedures.

The acquisition includes OrthoGrid’s AI-powered, fluoroscopy-based surgical assistance platform Hip AI as well as two additional FDA-cleared orthopedic applications and more than 40 patents, the company announced this week.

The transaction is expected to be completed by the end of the fourth quarter of 2024. Financial details were not disclosed.

The orthopedics-focused medical technology company said the proposed acquisition will expand its hip portfolio with AI-driven surgical guidance system.

“OrthoGrid’s AI systems address the rapidly growing market demand for fluoroscopy-based surgical guidance solutions while strengthening our portfolio of hip offerings that drive intraoperative efficiencies and improve the quality of life...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Medical Devices, Mergers & Acquisitions / JV, Technology, Trends
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article